Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Moodys
McKesson
McKinsey
Harvard Business School
AstraZeneca

Last Updated: August 17, 2022

MOMETASONE FUROATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


When do Mometasone Furoate patents expire, and what generic alternatives are available?

Mometasone Furoate is a drug marketed by Anda Repository, Cosette, Fougera Pharms, Glenmark Generics, Taro, Padagis Israel, Padagis Us, Torrent, Amneal Pharms, and Apotex Inc. and is included in twenty NDAs.

The generic ingredient in MOMETASONE FUROATE is mometasone furoate. There are thirty drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the mometasone furoate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Mometasone Furoate

A generic version of MOMETASONE FUROATE was approved as mometasone furoate by PADAGIS US on March 18th, 2002.

  Try it Free

Drug patent expirations by year for MOMETASONE FUROATE
Drug Prices for MOMETASONE FUROATE

See drug prices for MOMETASONE FUROATE

Drug Sales Revenue Trends for MOMETASONE FUROATE

See drug sales revenues for MOMETASONE FUROATE

Paragraph IV (Patent) Challenges for MOMETASONE FUROATE
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
NASONEX Nasal Spray mometasone furoate 50 mcg/ Spray 020762 1 2009-08-07
ELOCON Topical Solution (Lotion) mometasone furoate 0.1% 019796 1 2004-06-10

US Patents and Regulatory Information for MOMETASONE FUROATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Anda Repository MOMETASONE FUROATE mometasone furoate CREAM;TOPICAL 076591-001 Apr 18, 2007 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Torrent MOMETASONE FUROATE mometasone furoate OINTMENT;TOPICAL 207899-001 Jul 13, 2018 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Cosette MOMETASONE FUROATE mometasone furoate LOTION;TOPICAL 077678-001 Nov 21, 2007 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Glenmark Generics MOMETASONE FUROATE mometasone furoate CREAM;TOPICAL 078541-001 May 28, 2008 AB RX No Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
Anda Repository MOMETASONE FUROATE mometasone furoate OINTMENT;TOPICAL 076481-001 Nov 14, 2003 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Apotex Inc MOMETASONE FUROATE mometasone furoate SPRAY, METERED;NASAL 091161-001 Mar 22, 2016 AB RX No Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Boehringer Ingelheim
AstraZeneca
McKesson
Harvard Business School
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.